Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility
22/07/2026 11:35
BRIEF-Wanbury Says Completion Of US FDA Inspection At Tanuku Facility July 22 (Reuters) - Wanbury Ltd WANB.NS:
WANBURY - COMPLETION OF USFDA INSPECTION AT TANUKU FACILITY
WANBURY LTD - USFDA HAS ISSUED A FORM 483 WITH SIX OBSERVATIONS
Source text: ID:nBSEbr5ZZH
Further company coverage: WANB.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Wanbury
See all newsBrief: Wanbury Ltd Receives 9 “No DMF Deficiency” Letters From USFDA For Metformin HCl
Brief: Wanbury Files New Drug Master File In South Africa For Tramadol Hcl API
Brief: Wanbury June-Quarter PAT 32.4 Million Rupees
Brief: Wanbury Receives No DMF Deficiency Letter From USFDA For Multiple Andas
Brief: Wanbury Says Completion Of US FDA Inspection At Tanuku Facility